Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Higgins

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
FEBS Letters|February 15, 2003
Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6Suzanne Camus, Maureen Higgins, David P Lane, et al.
Scientific Reports|May 25, 2016
Loss of Nrf2 abrogates the protective effect of Keap1 downregulation in a preclinical model of cutaneous squamous cell carcinomaElena V Knatko, Maureen Higgins, Jed W Fahey, et al.
DNA Repair|August 7, 2009
Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domainSridevi Yadavilli, Lindsey D Mayo, Maureen Higgins, et al.
Planta Medica|March 21, 2013
NAD(P)H : quinone oxidoreductase 1 inducer activity of some Saudi Arabian medicinal plantsAbdelaaty A Shahat, Mansour S Alsaid, Muhammad A Alyahya, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2013
Synthesis and biological evaluation of biotin conjugates of (±)-(4bS,8aR,10aS)-10a-ethynyl-4b,8,8-trimethyl-3,7-dioxo-3,4b,7,8,8a,9,10,10a-octahydro-phenanthrene-2,6-dicarbonitrile, an activator of the Keap1/Nrf2/ARE pathway, for the isolation of its protein targetsAkira Saito, Maureen Higgins, Suqing Zheng, et al.
The Journal of Biological Chemistry|February 13, 2003
Oligomerization of the human ARF tumor suppressor and its response to oxidative stressSergio Menéndez, Zeb Khan, David W Coomber, et al.
European Journal of Medicinal Chemistry|June 6, 2020
Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moietyAiten M Soliman, Heba M Karam, Mai H Mekkawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 15, 2014
Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamidesMostafa M Ghorab, Maureen Higgins, Mansour S Alsaid, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2021
Novel iodinated quinazolinones bearing sulfonamide as new scaffold targeting radiation induced oxidative stressAiten M Soliman, Mai H Mekkawy, Heba M Karam, et al.
Oncotarget|February 15, 2011
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapyBhavya Rao, Ingeborg M M van Leeuwen, Maureen Higgins, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
FEBS Letters|February 15, 2003
Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6Suzanne Camus, Maureen Higgins, David P Lane, et al.
Scientific Reports|May 25, 2016
Loss of Nrf2 abrogates the protective effect of Keap1 downregulation in a preclinical model of cutaneous squamous cell carcinomaElena V Knatko, Maureen Higgins, Jed W Fahey, et al.
DNA Repair|August 7, 2009
Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domainSridevi Yadavilli, Lindsey D Mayo, Maureen Higgins, et al.
Planta Medica|March 21, 2013
NAD(P)H : quinone oxidoreductase 1 inducer activity of some Saudi Arabian medicinal plantsAbdelaaty A Shahat, Mansour S Alsaid, Muhammad A Alyahya, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2013
Synthesis and biological evaluation of biotin conjugates of (±)-(4bS,8aR,10aS)-10a-ethynyl-4b,8,8-trimethyl-3,7-dioxo-3,4b,7,8,8a,9,10,10a-octahydro-phenanthrene-2,6-dicarbonitrile, an activator of the Keap1/Nrf2/ARE pathway, for the isolation of its protein targetsAkira Saito, Maureen Higgins, Suqing Zheng, et al.
The Journal of Biological Chemistry|February 13, 2003
Oligomerization of the human ARF tumor suppressor and its response to oxidative stressSergio Menéndez, Zeb Khan, David W Coomber, et al.
European Journal of Medicinal Chemistry|June 6, 2020
Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moietyAiten M Soliman, Heba M Karam, Mai H Mekkawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 15, 2014
Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamidesMostafa M Ghorab, Maureen Higgins, Mansour S Alsaid, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2021
Novel iodinated quinazolinones bearing sulfonamide as new scaffold targeting radiation induced oxidative stressAiten M Soliman, Mai H Mekkawy, Heba M Karam, et al.
Oncotarget|February 15, 2011
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapyBhavya Rao, Ingeborg M M van Leeuwen, Maureen Higgins, et al.
Pageof 6